Welcome to Collagen
medical LLC
Collagen Medical is a pre-clinical
stage specialty pharmaceutical company based in Boston, MA engaged in
developing targeted magnetic resonance imaging (MRI) contrast agents to
diagnose and stage fibrotic disease and assess response to therapeutic
interventions. Serious chronic diseases such as heart failure,
atrial fibrillation, steatohepatitis, hepatitis C, and pulmonary
fibrosis affect tens of millions of patients in the US. All of
these diseases are characterized by fibrosis that is strongly linked to
poor prognosis. There is a major unmet medical need for improved
diagnostic techniques to identify and stratify patients, predict risk
of disease progression and guide therapy. Collagen Medical’s
targeted imaging technology will enable highly sensitive and specific
three-dimensional mapping of fibrosis within target organs, providing
clinicians with the means to diagnose and manage disease in a minimally
invasive manner. Collagen Medical’s technology has also been
validated for high resolution assessment of myocardial perfusion to
identify coronary artery disease imaging cardiac perfusion.